Weekly Twitter Roundup

Posted by Dan Vorhaus on February 5, 2010

Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:

RT @DukeIGSP: Myriad’s profits rise. CEO says publicity from gene patent suit has benefited company. http://bit.ly/cRU1KR
Costs Saving from Personalized Medicine Sought by PBMs, Employers, Pharma Face Legal, Privacy Hurdles http://bit.ly/dsn4hB (@crossborderbio)
CancerGuide closes on $10.5M in financing; secures LabCorp as partner: http://bit.ly/d9vTdi
RT @markgfh: My Eureka Science Matters column about balance in science reporting http://bit.ly/askPCn
New CDC RFA for “Knowledge Synthesis Center for Evaluating Genomic Application in Practice & Prevention”: http://bit.ly/cAQZ91
SOLiD Gold: Dietrich Stephan on Ignite’s Partnership with Life Technologies http://bit.ly/dhgf1a (via @bioitworld)
RT @tgoetz Moore who? Fast Company points out the great irony: only in healthcare does technology INCREASE costs. http://bit.ly/8ZHhMH
Genomic Health Q4 Revenues also up. Will incr. sales of Oncotype Dx breast & (new) colon cancer test=’10 profitability? http://bit.ly/a8LFUU
Affymetrix Q4 Revenues Up 13% spurred by increased demand for genotyping products: http://bit.ly/bwKhIu (@GenomeWeb_News)
RT @DukeIGSP: What do personal genomes & the iPad have in common? Misha Angrist has an answer http://bit.ly/9X7DDh
Harvard, InnoCentive Launch New Diabetes Project-Crowdsourcing both Questions & Answers: http://bit.ly/dsKRt8 (HT @jensmccabe)
RT @timjph: More money lined to ELIXIR, Europe’s bioinformatics e-infrastructure project: Finland announces investment http://bit.ly/beZp4d
“In ACLU v. Myriad, It’s Scientific Accuracy, 0, and Wild Speculation, 1″ http://bit.ly/bOqBdD (GenomeWeb)
“Wiping Out Human Variation” / Guardian on @counsyl http://bit.ly/bKnazc Good story, questions; abominable & misleading title.
P&G partners with @Navigenics in $18M Series C round. http://bit.ly/bmXak4 Demonstrates diversity, expansion of DTC/PersMed
Teva’s BLA for Neupoval is accepted at the FDA. What it means for future of US Biosimilars. http://ow.ly/13fUE (@crossborderbio)
RT @crossborderbio, @FierceBiotech: Ironwood raises $188M in IPO but takes big price cut. http://bit.ly/dbMdtE
RT @nanopore: brilliant list .RT @TimesScience: Eureka’s Top 30 Science Blogs http://bit.ly/bPPrhR
IHEC Launches. RT @EdwardWinstead: 1,000 reference epigenomes within a decade http://bit.ly/biHWg2 @NatureNews
Up Next in Gene Patents: Waiting for a Ruling (Again) and SACGHS Meets (Again): http://bit.ly/cLrqQd
Final Words from the Sidelines as Courtroom Arguments Begin in Gene Patent Litigation: http://bit.ly/bwpblq
Bob Barr speaks out against a national healthcare information database, citing privacy concerns: http://bit.ly/aX7way
Docs, dentists and vets all petition FTC for an exemption from “red flag” rules: http://bit.ly/c5kXR0
Psychologist Stephen Pinker tests @counsyl’s genetic screen (and finds a match): http://bit.ly/asKGuScouns RT @techreview
Corp. wellness programs & GINA (which bars employers from collecting gen info, incl. family history) at odds: http://bit.ly/aKhe5w
Genetic counselors weigh in on the pros/cons of @counsyl genetic screening test: http://bit.ly/9awHqz & http://bit.ly/a8baFG
Medco Acquires DNA Direct to Expand PGx Offerings: http://bit.ly/9m4X4P & http://bit.ly/cLpxaw (HT @jasonbobe)
RT @nutrigenomics, @NatRevDrugDisc: Pharma in 2020: 4 potential future scenarios based on discussions w/ experts http://bit.ly/9BprCV
RT @GW_The_Sample: ACLA Briefs Blues Chapter About ‘Value of Genetic Testing’: http://bit.ly/9NolFA
Newborn Blood Spot Litigation: 70 Days to Destroy 5+ Million Samples: http://bit.ly/dsA00w
Summary judgment arguments in ACLU/Myriad gene patent litigation are tomorrow. Globe weighs in with op-ed http://bit.ly/de4JFN
RT @Berci: The Top 10 Barriers to EHR Implementation by John D. Halamka http://ff.im/-fdSsu
RT @HFDigest: RT @ahier Will the iPad Revolutionize Healthcare? http://bit.ly/ah7y6k
Federal committee recommends adding SCID to uniform newborn screening panel. 1st condition added since ’05: http://bit.ly/8ZvbU
RT @gw_dailyscan: Congrats, Utah: Genomics education sites win an award. http://bit.ly/cVNAvp
RT @ldtimmerman: Cambridge, MA-based Ironwood Pharma gears up for industry’s biggest IPO in years. http://bit.ly/clJi3S
RT @nanopore, @ldtimmerman: $ILMN bets again on Oxford Nanopore, joins $28m investment in cheaper gene sequencing http://bit.ly/9ImTnH
RT @wilbanks, @creativecommons: CC and open education plans, projects, team for 2010 http://creativecommons.org/weblog/entry/20329 #OER
RT @ericneumann: RT @Richard_Dawkins Eight Percent of Human Genetic Material Comes from a Virus http://is.gd/6Reqp
RT @cheriewoodward New PPAC (patent public advisory comm.) members & chair announced http://preview.tinyurl.com/yzmrxwd (via @PatentDocs)
RT @phylogenomics: Bad omics word of the day: phenogenomics, the omics of phenotype?, also known as genetics I believe http://ff.im/-f6Vy8
AMP releases position statement on “Oversight of LDTs”: http://bit.ly/9JCwkn Hard to tell what “position” is: status quo, reg, or both?
Firm Brings Gene Tests to the Masses: http://bit.ly/dfsI2y NYT discusses @Counsyl’s hope and hype
The other side of the iPad for healthcare: 9 Reasons iPad falls short for acute care: http://bit.ly/df5She (via @mobilehealth)
RT @genetizen: Medicine is the Apple iPad sweet spot http://healthcare.zdnet.com/?p=3257